U.S. Senate Finance Committee Chair Ron Wyden (D-OR) has announced the expansion of his ongoing investigation into the tax practices of multinational pharmaceutical companies with a new letter sent to the CEO of Pfizer on Monday 20 May 2024.

---

Wyden Expands Big Pharma Tax Investigation with Pfizer Inquiry

New Letter to Pfizer CEO Builds on Three-Year Committee Investigation; The U.S. Is …